method and kit for detecting hepatitis c virus in a dried biological fluid sample, and method for selecting a patient presenting with hepatitis symptoms.

摘要

The present disclosure provides for rapid and non-invasive methods for determining whether a patient will benefit from treatment with therapeutic agents that inhibit hepatitis c virus (hcv). These methods are based on the detection of vhc rna and / or anti-hcv antibodies in small volume dried biological fluid samples that are collected using a micro sample device. Kits are also provided for use in practicing the methods.